blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

Latvia joins the Federated Register
Click here for more information on the Federated Register.

2025-04-16

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3242931

EP3242931 - FORMULATIONS FOR STABILIZING BACTERIAL CELL EXTRACTS [Right-click to bookmark this link]
Former [2017/46]FORMULATIONS FOR DRYING BACTERIAL CELL EXTRACTS
[2020/44]
StatusNo opposition filed within time limit
Status updated on  04.02.2022
Database last updated on 03.05.2025
FormerThe patent has been granted
Status updated on  26.02.2021
FormerGrant of patent is intended
Status updated on  11.10.2020
FormerExamination is in progress
Status updated on  15.05.2020
FormerRequest for examination was made
Status updated on  13.10.2017
FormerThe international publication has been made
Status updated on  04.08.2017
Most recent event   Tooltip20.12.2024Lapse of the patent in a contracting state
New state(s): GR
published on 22.01.2025  [2025/04]
Applicant(s)For all designated states
Sutro Biopharma, Inc.
310 Utah Avenue, Suite 150
South San Francisco, California 94080 / US
[2021/27]
Former [2017/46]For all designated states
Sutro Biopharma, Inc.
310 Utah Street, Suite 150
South San Francisco, California 94080 / US
Inventor(s)01 / CHANDLER, Martin
310 Utah Avenue, Suite 150
South San Francisco, CA 94080 / US
02 / HAYENGA, Kirk
310 Utah Avenue, Suite 150
South San Francisco, CA 94080 / US
03 / HEINSOHN, Henry
310 Utah Avenue, Suite 150
South San Francisco, CA 94080 / US
 [2021/27]
Former [2021/13]01 / CHANDLER, Martin
310 Utah Street, Suite 150
South San Francisco, CA 94080 / US
02 / HAYENGA, Kirk
310 Utah Street, Suite 150
South San Francisco, CA 94080 / US
03 / HEINSOHN, Henry
310 Utah Street, Suite 150
South San Francisco, CA 94080 / US
Former [2017/46]01 / CHANDLER, Martin
310 Utah Street Suite 150
South San Francisco, CA 94080 / US
02 / HAYENGA, Kirk
310 Utah Street Suite 150
South San Francisco, CA 94080 / US
03 / HEINSOHN, Henry
310 Utah Street Suite 150
South San Francisco, CA 94080 / US
Representative(s)Geling, Andrea
ZSP Patentanwälte PartG mbB
Hansastraße 32
80686 München / DE
[2017/46]
Application number, filing date16735454.708.01.2016
[2017/46]
WO2016US12599
Priority number, dateUS201562101266P08.01.2015         Original published format: US 201562101266 P
[2017/46]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016112258
Date:14.07.2016
Language:EN
[2016/28]
Type: A1 Application with search report 
No.:EP3242931
Date:15.11.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 14.07.2016 takes the place of the publication of the European patent application.
[2017/46]
Type: B1 Patent specification 
No.:EP3242931
Date:31.03.2021
Language:EN
[2021/13]
Search report(s)International search report - published on:US14.07.2016
(Supplementary) European search report - dispatched on:EP26.06.2018
ClassificationIPC:C12P21/00, C12P1/04, C12P21/02, C12P21/04, C12N1/04, C07K14/535, C07K16/00
[2018/30]
CPC:
C12P21/02 (EP,US); C12P21/00 (US); C07K14/535 (US);
C07K16/00 (US); C12P1/04 (EP,US)
Former IPC [2017/46]C12N1/04
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/46]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:FORMULIERUNGEN ZUR STABILISIERUNG VON BAKTERIENZELLENEXTRAKTEN[2020/44]
English:FORMULATIONS FOR STABILIZING BACTERIAL CELL EXTRACTS[2020/44]
French:FORMULATIONS POUR LA STABILISATION D'EXTRAITS DE CELLULES BACTÉRIENNES[2020/44]
Former [2017/46]FORMULIERUNGEN ZUR TROCKNUNG VON BAKTERIENZELLENEXTRAKTEN
Former [2017/46]FORMULATIONS FOR DRYING BACTERIAL CELL EXTRACTS
Former [2017/46]FORMULATIONS POUR LA LYOPHILISATION D'EXTRAITS DE CELLULES BACTÉRIENNES
Entry into regional phase02.08.2017National basic fee paid 
02.08.2017Search fee paid 
02.08.2017Designation fee(s) paid 
02.08.2017Examination fee paid 
Examination procedure02.08.2017Examination requested  [2017/46]
02.08.2017Date on which the examining division has become responsible
09.01.2019Amendment by applicant (claims and/or description)
19.05.2020Despatch of a communication from the examining division (Time limit: M04)
16.09.2020Reply to a communication from the examining division
12.10.2020Communication of intention to grant the patent
22.02.2021Fee for grant paid
22.02.2021Fee for publishing/printing paid
22.02.2021Receipt of the translation of the claim(s)
Opposition(s)04.01.2022No opposition filed within time limit [2022/10]
Fees paidRenewal fee
15.01.2018Renewal fee patent year 03
15.01.2019Renewal fee patent year 04
14.01.2020Renewal fee patent year 05
13.01.2021Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU08.01.2016
AL31.03.2021
CY31.03.2021
CZ31.03.2021
EE31.03.2021
ES31.03.2021
FI31.03.2021
GR31.03.2021
HR31.03.2021
IT31.03.2021
LT31.03.2021
LV31.03.2021
MC31.03.2021
MK31.03.2021
MT31.03.2021
PL31.03.2021
RO31.03.2021
RS31.03.2021
SI31.03.2021
SK31.03.2021
SM31.03.2021
TR31.03.2021
BG30.06.2021
IS31.07.2021
PT02.08.2021
[2025/04]
Former [2024/42]HU08.01.2016
AL31.03.2021
CY31.03.2021
CZ31.03.2021
EE31.03.2021
ES31.03.2021
FI31.03.2021
HR31.03.2021
IT31.03.2021
LT31.03.2021
LV31.03.2021
MC31.03.2021
MK31.03.2021
MT31.03.2021
PL31.03.2021
RO31.03.2021
RS31.03.2021
SI31.03.2021
SK31.03.2021
SM31.03.2021
TR31.03.2021
BG30.06.2021
IS31.07.2021
PT02.08.2021
Former [2024/29]HU08.01.2016
AL31.03.2021
CY31.03.2021
CZ31.03.2021
EE31.03.2021
ES31.03.2021
FI31.03.2021
HR31.03.2021
IT31.03.2021
LT31.03.2021
LV31.03.2021
MC31.03.2021
MK31.03.2021
PL31.03.2021
RO31.03.2021
RS31.03.2021
SI31.03.2021
SK31.03.2021
SM31.03.2021
TR31.03.2021
BG30.06.2021
IS31.07.2021
PT02.08.2021
Former [2024/22]HU08.01.2016
AL31.03.2021
CY31.03.2021
CZ31.03.2021
EE31.03.2021
ES31.03.2021
FI31.03.2021
HR31.03.2021
IT31.03.2021
LT31.03.2021
LV31.03.2021
MC31.03.2021
MK31.03.2021
PL31.03.2021
RO31.03.2021
RS31.03.2021
SI31.03.2021
SK31.03.2021
SM31.03.2021
BG30.06.2021
IS31.07.2021
PT02.08.2021
Former [2024/20]HU08.01.2016
AL31.03.2021
CY31.03.2021
CZ31.03.2021
EE31.03.2021
ES31.03.2021
FI31.03.2021
HR31.03.2021
IT31.03.2021
LT31.03.2021
LV31.03.2021
MC31.03.2021
PL31.03.2021
RO31.03.2021
RS31.03.2021
SI31.03.2021
SK31.03.2021
SM31.03.2021
BG30.06.2021
IS31.07.2021
PT02.08.2021
Former [2024/18]HU08.01.2016
AL31.03.2021
CZ31.03.2021
EE31.03.2021
ES31.03.2021
FI31.03.2021
HR31.03.2021
IT31.03.2021
LT31.03.2021
LV31.03.2021
MC31.03.2021
PL31.03.2021
RO31.03.2021
RS31.03.2021
SI31.03.2021
SK31.03.2021
SM31.03.2021
BG30.06.2021
IS31.07.2021
PT02.08.2021
Former [2022/39]AL31.03.2021
CZ31.03.2021
EE31.03.2021
ES31.03.2021
FI31.03.2021
HR31.03.2021
IT31.03.2021
LT31.03.2021
LV31.03.2021
MC31.03.2021
PL31.03.2021
RO31.03.2021
RS31.03.2021
SI31.03.2021
SK31.03.2021
SM31.03.2021
BG30.06.2021
IS31.07.2021
PT02.08.2021
Former [2022/36]AL31.03.2021
CZ31.03.2021
EE31.03.2021
ES31.03.2021
FI31.03.2021
HR31.03.2021
IT31.03.2021
LT31.03.2021
LV31.03.2021
PL31.03.2021
RO31.03.2021
RS31.03.2021
SI31.03.2021
SK31.03.2021
SM31.03.2021
BG30.06.2021
IS31.07.2021
PT02.08.2021
Former [2022/29]AL31.03.2021
CZ31.03.2021
EE31.03.2021
ES31.03.2021
FI31.03.2021
HR31.03.2021
LT31.03.2021
LV31.03.2021
PL31.03.2021
RO31.03.2021
RS31.03.2021
SI31.03.2021
SK31.03.2021
SM31.03.2021
BG30.06.2021
IS31.07.2021
PT02.08.2021
Former [2022/23]AL31.03.2021
CZ31.03.2021
EE31.03.2021
ES31.03.2021
FI31.03.2021
HR31.03.2021
LT31.03.2021
LV31.03.2021
PL31.03.2021
RO31.03.2021
RS31.03.2021
SK31.03.2021
SM31.03.2021
BG30.06.2021
IS31.07.2021
PT02.08.2021
Former [2022/10]AL31.03.2021
CZ31.03.2021
EE31.03.2021
ES31.03.2021
FI31.03.2021
HR31.03.2021
LT31.03.2021
LV31.03.2021
PL31.03.2021
RO31.03.2021
RS31.03.2021
SK31.03.2021
SM31.03.2021
BG30.06.2021
PT02.08.2021
IS24.12.2021
Former [2022/08]AL31.03.2021
CZ31.03.2021
EE31.03.2021
ES31.03.2021
FI31.03.2021
HR31.03.2021
LT31.03.2021
LV31.03.2021
PL31.03.2021
RO31.03.2021
RS31.03.2021
SK31.03.2021
SM31.03.2021
BG30.06.2021
IS31.07.2021
PT02.08.2021
Former [2022/07]AL31.03.2021
CZ31.03.2021
EE31.03.2021
FI31.03.2021
HR31.03.2021
LT31.03.2021
LV31.03.2021
PL31.03.2021
RO31.03.2021
RS31.03.2021
SK31.03.2021
SM31.03.2021
BG30.06.2021
IS31.07.2021
PT02.08.2021
Former [2021/52]CZ31.03.2021
EE31.03.2021
FI31.03.2021
HR31.03.2021
LT31.03.2021
LV31.03.2021
PL31.03.2021
RO31.03.2021
RS31.03.2021
SK31.03.2021
SM31.03.2021
BG30.06.2021
IS31.07.2021
PT02.08.2021
Former [2021/51]CZ31.03.2021
EE31.03.2021
FI31.03.2021
HR31.03.2021
LT31.03.2021
LV31.03.2021
RO31.03.2021
RS31.03.2021
SK31.03.2021
SM31.03.2021
BG30.06.2021
IS31.07.2021
PT02.08.2021
Former [2021/50]CZ31.03.2021
EE31.03.2021
FI31.03.2021
HR31.03.2021
LT31.03.2021
LV31.03.2021
RO31.03.2021
RS31.03.2021
SK31.03.2021
SM31.03.2021
BG30.06.2021
PT02.08.2021
Former [2021/48]CZ31.03.2021
EE31.03.2021
FI31.03.2021
HR31.03.2021
LT31.03.2021
LV31.03.2021
RS31.03.2021
SM31.03.2021
BG30.06.2021
Former [2021/46]FI31.03.2021
HR31.03.2021
LT31.03.2021
LV31.03.2021
RS31.03.2021
SM31.03.2021
BG30.06.2021
Former [2021/37]FI31.03.2021
HR31.03.2021
LV31.03.2021
RS31.03.2021
BG30.06.2021
Former [2021/36]FI31.03.2021
HR31.03.2021
BG30.06.2021
Former [2021/35]FI31.03.2021
HR31.03.2021
Former [2021/34]FI31.03.2021
Cited inInternational search[Y]EP0259739  (MILES LAB [US]);
 [A]US2012230976  (HELMERHORST EVA J [US], et al);
 [Y]WO2014004639  (SUTRO BIOPHARMA INC [US]);
ExaminationUS7048915
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.